FDA Investigator Michael Gurbarg
Michael Gurbarg has conducted inspections on 12 sites in 1 countries as of 07 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
07 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Michael Gurbarg:
Alla Kachko, PhD,
Amy L Singer,
Anastasia I Offordile,
Anastasia I Onuorah,
Anastasia M Shields,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie Bodnar,
Anthony A Charity,
Audrey Thereset Uy,
Barbara Jwilimczyk Macri,
Brentley S Collins,
Brian S Keefer,
CDR Jeremy L Wally, PhD,
Chao Ming Tsai,
Charles M Edwards,
Christian D Lynch (CDL),
Christina J Sauder, PhD,
Christopher J Adams,
Colleen M Damon,
Craig D Zagata,
Cynthia Jim, CSO,
Dave Hafner,
David A Oluwo,
David J Hafner,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Edward D Mcdonald,
Eileen A Liu,
Ellen Huang,
Emest F Bizjak,
Erika V Butler,
Frank W Perrella,
Frederick F Razzaghi,
Gayle S Lawson,
Gene D Arcy,
George Pyramides,
H Ljamilla Selby,
Hala L Selby,
Hala Lj Whetstone,
Haruhiko Murata,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
Jaison J Eapen,
James C Illuminati,
James M Mason,
James P Mcevoy,
Jean Blackston Hill,
Jeen S Min,
Joan A Loreng,
Joan Adamo,
Joanne Heim,
Joanne M Hajoway,
Jose M Cayuela,
Joseph George,
Joseph L Despins, PhD,
Julianne C Mccullough,
Junho Pak,
Karyn M Campbell,
Kathleen B Mihalik,
Kathryn Carbone, MD,
Kelli F Dobilas,
Kelly N Kerr,
Kendra L Brooks,
Kenneth M Gordon,
Ko U Min,
Kristen D Evans,
Kristina J Donohue,
Kristina L Conroy,
Kristina Mjoyce Pittman,
Kristy A Zielny,
Lauren L Vajo,
LCDR Margaret Edi Gennaro,
Linda M Hoover,
Linda Thai,
Lisa B Orr,
Lisa M Bellows,
Lisa M Feola,
LT John M Mastalski,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Maria Estrella,
Marian E Major, PhD,
Matthew R Noonan,
Michael Curbarg,
Michael L Casner,
Michele Gottshall,
Michele M Falchek,
Mihaly S Ligmond,
Niketa Patel,
Omotunde O Osunsanmi,
Paul L Bellamy,
Paula A Trost,
Prabhu P Raju,
Rabin N Ghoshal,
Raffi B Papazian,
Ramon E Martinez,
Rebecca K Olin,
Regina T Brown,
Richard E Needham,
Robert B Shibuya, MD,
Robert D Tollefsen,
Robert J Maffei,
Rochelle L Massey,
Rose Ashley,
Sam Pepe,
Scott E Norris,
Sharon K Thoma, PharmD,
Sheila Dreher Lesnick,
Shuang Tang,
Simone E Pitts,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Stephen J Koniers,
Steven A Rubin,
Susan F Laska, MS,
Tammy L Chavis,
Temar Q Williams,
Thomas E Friel,
Tina S Roecklein,
Vlada Matusovsky,
Wei Wang, PhD,
Xiao Wang,
Yvonne C Mcknight,
Yvonne C Wood
Michael Gurbarg's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2000 | EIR | Accupac, LLC - EIR, 2000-04-13 |
March, 2001 | FDA 483 | Pharmaceutical Manufacturing Research Services, Inc. - Form 483, 2001-03-28 |
October, 2001 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2001-10-29 |
April, 2000 | FDA 483 | Accupac, LLC - Form 483, 2000-04-13 |
October, 2001 | FDA 483 Response | Merck Sharp & Dohme LLC - Form 483R, 2001-11-19 |
October, 2001 | EIR | Merck Sharp & Dohme LLC - EIR, 2001-10-29 |
March, 2001 | EIR | Pharmaceutical Manufacturing Research Services, Inc. - EIR, 2001-03-28 |
March, 2000 | FDA 483 | Johnson & Johnson Consumer Inc. - Form 483, 2000-03-09 |
March, 2000 | EIR | Johnson & Johnson Consumer Inc. - EIR, 2000-03-09 |
April, 2000 | FDA 483 Response | Accupac, LLC - Form 483R, 2000-05-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more